DalsnaFinance › IPOs › Sutro Biopharma › IPO
SUTRO BIOPHARMA, INC. completed its initial public offering on NASDAQ on September 27, 2018, pricing at $15.00 a share.
| Ticker | STRO |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 27, 2018 |
| Offering price | $15.00 |
| Shares offered | 5,667,000 |
| Total raised | $85M |
SUTRO BIOPHARMA, INC. sold 5,667,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $85 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $85 million total recorded for the deal.
SUTRO BIOPHARMA, INC. — quote, profile and latest news →
Source: SEC EDGAR filings for SUTRO BIOPHARMA, INC.. This page is general information, not investment advice.